Trial 10M-14-4


Phase III, Randomized, Double-Blind, Multicenter Trial Of Autologous Dendritic Cells Loaded With Irradiated Autologous Tumor Cells (NBS20) Vs. Autologous Peripheral Blood Mononuclear Cell Control (MC), Both Coadministered With Adjuvant GM-CSF, For The Treatment Of Patients With Metastatic Melanoma

Type: Treatment
Phase: Phase III
Status: Not Open (Closed)
Treatments: Other
Randomized: Yes
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  James Hu, M.D.
Other Trial Staff:  Gina Tse, R.N., Eduardo Mejia, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.